A major review has provoked a backlash after concluding the medicines provide too little benefit to be noticed.
Trending
- From OpenStreetMap to Power BI: Visualizing Wild Swimming Locations
- New AT&T Elite 2.0 Phone Plan Boosts Wireless Hotspot and Data Performance
- 'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests
- ChatGPT’s new ‘Thinking’ mode just hit a 94% reasoning score — 7 prompts it can solve that standard AI can’t
- 5 Practical Tips for Transforming Your Batch Data Pipeline into Real-Time: Upcoming Webinar
- NYT Connections hints and answers for Thursday, April 16 (game #1040)
- AI Safety Benchmarks Are Falling Behind
- Today’s NYT Mini Crossword Answers for April 16
